forty patients with severe bacterial infections due to micro-organisms known or presumed to be sensitive to both study antibiotics , were randomized to receive either imipenem with cilastatin , 500 mg/500 mg iv tid ( 20 patients ) , or cefotaxime , 2 g iv tid ( 20 patients ) .
C0004623
bacterial infections
C0007554
cefotaxime